General
Novo Nordisk CEO Lars Fruergaard Jorgensen to resign as Ozempic faces stiff competition
The CEO of Danish pharmaceutical giant Novo Nordisk, known for its blockbuster weight-loss drug Ozempic, will step down following a plunge in the company’s share price, the drug maker said on Friday.
The company said it was searching for a successor for Lars Fruergaard Jorgensen, who has held the…
Continue Reading
-
Noosa News20 hours agoTruck carrying wind turbine gets stuck under Mount Crosby Bridge closing Warrego Highway
-
Noosa News24 hours agoRSPCA Noosa closes, Councils partner to help lost pets
-
General23 hours agoRoad death toll nears 100 in Queensland with three fatalities in two days
-
Noosa News18 hours agoQueensland’s most dangerous roads for motorcyclists revealed